DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Brecanavir
Brecanavir
WO 2018/005909 Al 04 January 2018 (04.01.2018) W !P O PCT
Download Article PDF/Slides
Ep 2531027 B1
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
GSK and Vertex Pharmaceuticals Announce Presentation of Data Supporting Development of Investigational HIV Protease Inhibitor Brecanavir
Screening of Clinically Approved and Investigation Drugs As Potential
Section 2.6.4 Pharmacokinetics Written Summary EMTRICITABINE
WO 2017/191545 Al 09 November 2017 (09.11.2017) W !P O PCT
Current and Novel Inhibitors of HIV Protease
N° 18583 C07d 239/94 (2018.01) C07d 401/12 (2018.01)
Stembook 2018.Pdf
Antiviral Drugs in the Treatment of Aids: What Is in the Pipeline ?
Knowledge-Graph-Based Drug Repositioning Against COVID-19 by Graph Convolutional Network with Attention Mechanism
Advances in Antiretroviral Therapy Volume 15 Issue 2 April/May 2007
Women's Interagency Hiv Study Drug List 1
Research 1..51
Repurposing of FDA Approved Drugs
TABLE 2. HIV Treatment Pipeline 2003–2012 Class Drug Name Generic Name Brand Name Sponsor 2003 2004 2005 2006 2007 2008 2009 2
Top View
Pharmaceutical Appendix to the Tariff Schedule 2
Women's Interagency Hiv Study Drug List 1 – By
Antiretroviral Drugs: Critical Issues and Recent Advances
WO 2017/035230 Al 2 March 2017 (02.03.2017) P O P C T
Women's Interagency Hiv Study Drug List 1 – By
HIV 102:Care & Treatment
Parenteral Inhibitors of HIV Entry in Current Development The
Human DNA-Damage-Inducible 2 Protein Is Structurally And
A Phase 2, Multicenter, Open-Label Study of BGJ398 in Patients with Recurrent Resectable Or Unresectable Glioblastoma
Computational Study Based on Molecular Topology
New Antivirals and Drug Resistance
In Silico Evaluation of the Effectivity of Approved Protease Inhibitors
(12) United States Patent (10) Patent No.: US 8,703,801 B2 Nair Et Al
WO 2015/196116 Al 23 December 2015 (23.12.2015) P O P C T
Wo 2012/048204 A2
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
WO 2012/151165 Al 8 November 2012 (08.11.2012) P O P C T
2013 Pipeline Report
Recent Developments in HIV Treatment and Their Dissemination in Poor
WO 2017/205585 Al 30 November 20 7 (30
Combinations of Dolutegravir and Lamivudine for the Treaetment of Hiv Infection
2011 Pipeline Report Second Edition
Compositions Comprising Jak Inhibitors and Haart Drugs
Repurposing of Known Anti-Virals As Potential Inhibitors for SARS-Cov-2 Main Protease Using Molecular Docking Analysis
Women=S Interagency Hiv Study Drug List 1 B by Alphabet
Protease Inhibitor Plasma Concentrations in HIV Antiretroviral
Wo 2008/010953 A2
2012 Harmonized Tariff Schedule Pharmaceuticals Appendix